By Angus Chen April 12, 2022 Reprints Human T cells A. WALKER, L. SHARP & J. PRYDE./WELLCOME COLLECTION NEW ORLEANS — A couple months before the pandemic started, Joseph Ford started experiencing a rash of pinpoint polka dots around his lips, ankles, and lower legs. They were itchy, inflamed, painful, and, for him, the first...
by Leslie Orr, University of Rochester Medical Center Distribution of prognostic understanding regarding curability and life expectancy estimates reported by patients and oncologists. A, Patients and oncologists were asked about their beliefs about the curability of the cancer: “What do you believe are the chances the cancer will go away and never come back with...
by Oregon State University Credit: CC0 Public Domain Melanoma patients receiving therapy that helps their immune system kill cancer cells respond to treatment differently depending on the types of microbes in their gut, and new research suggests the microorganisms hindering therapy have more influence than the beneficial ones. Findings by a collaboration that included researchers...
by Caroline Wallace, Medical University of South Carolina Credit: Pixabay/CC0 Public Domain As a 10-year journey comes to fruition, Medical University of South Carolina (MUSC) Hollings Cancer Center researcher John O’Bryan, Ph.D., and colleagues have demonstrated a new therapeutic way to block a protein that is frequently mutated in cancers. These proof-of-principle findings were published...
by Johannes Angerer, Medical University of Vienna Figure 1. (A) Anti-S levels after the second and third vaccination dose in the Vienna cohort. (B) Anti-S levels after the first, second and third vaccination dose in the Meran cohort. Anti-S levels after the second dose were only determined if no seroconversion was seen after the first...
by La Trobe University Dr Amy Dennett conducts a telehealth rehabilitation appointment. Credit: La Trobe University La Trobe University research has found delivering cancer patients’ rehabilitation clinics by telehealth is safe, effective and removes barriers to participation, such as fatigue, travel and parking costs. Published in Journal of Medical Internet Research—Cancer, the study found 88...
Roxanne Nelson RN, BSN January 05, 2022 The antidepressant bupropion failed to improve sexual dysfunction in female cancer survivors, according to new findings. Using the Female Sexual Function Index (FSFI) as a measurement tool, investigators found that desire scores were not significantly different for participants who received bupropion versus a placebo over the 9-week study period. “Sexual health...
By Angus Chen Dec. 20, 2021 Reprints ADOBE As cancer-killing CAR-T cells course through the body, they make occasional pit stops at the gut. What they do there — and which gut microbes they meet up with — could potentially change the prospects of these engineered immune cells. Scientists are just beginning to tease apart the...
by Delft University of Technology Credit: Delft University of Technology Researchers from Delft University of Technology and the Netherlands Cancer Institute (NKI) have developed an algorithm to predict patient response to anti-cancer drugs. This allows us to identify more rapidly if some drugs can have a positive effect on a specific patient, even for complicated...
MASSACHUSETTS GENERAL HOSPITAL BOSTON – Two new studies indicate that immunotherapy may benefit people with leptomeningeal carcinomatosis (LMD), a rare but serious complication of cancer that has spread to the brain and/or spinal cord. The research, which was led by investigators at Massachusetts General Hospital (MGH), Dana-Farber Cancer Institute, and the Broad Institute, is published...
